Complete DiGeorge syndrome: Persistence of profound immunodeficiency

被引:87
作者
Markert, ML
Hummell, DS
Rosenblatt, HM
Schiff, SE
Harville, TO
Williams, LW
Schiff, RI
Buckley, RH
机构
[1] Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA
[3] Vanderbilt Univ, Med Ctr, Div Pediat Immunol, Nashville, TN USA
[4] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[5] Texas Childrens Hosp, Sect Allergy & Immunol, Houston, TX 77030 USA
关键词
D O I
10.1016/S0022-3476(98)70478-0
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: DiGeorge syndrome is characterized by developmental defects of the heart, parathyroid glands, and thymus. The objective of this study was to determine whether T-cell function spontaneously improves in patients with DiGeorge syndrome who have profoundly depressed T-cell proliferative responses to mitogens at presentation, regardless of the T-cell count. Study design: We conducted a retrospective chart review of eight patients with DiGeorge syndrome who had no proliferative responses to mitogens on presentation. Results: Despite lack of responsiveness of the patients' peripheral blood lymphocytes to mitogens, T cells were occasionally detected, and the patients' cells often responded to IL-2 and in mixed lymphocyte reactions. Unresponsiveness to mitogens and clinical immunodeficiency persisted without immune-based therapy One patient is alive and well after immunoreconstitution from thymic transplantation. The others either died early of complications of their disease such as gastroesophageal reflux with aspiration (2 patients) or infection (2 patients) or died after attempts at immunorestorative therapy with IL-2, thymus transplantation, or bone marrow transplantation (3 patients). Conclusion: Eight patients with DiGeorge syndrome who were first seen T with no mitogen responsiveness did not improve spontaneously. We recommend HLA-identical bone marrow transplantation or thymic transplantation for these patients as soon as the diagnosis is confirmed.
引用
收藏
页码:15 / 21
页数:7
相关论文
共 16 条
[1]  
BARRETT DJ, 1981, J CLIN LAB IMMUNOL, V6, P1
[2]   PREDICTION OF PERSISTENT IMMUNODEFICIENCY IN THE DIGEORGE ANOMALY [J].
BASTIAN, J ;
LAW, S ;
VOGLER, L ;
LAWTON, A ;
HERROD, H ;
ANDERSON, S ;
HOROWITZ, S ;
HONG, R .
JOURNAL OF PEDIATRICS, 1989, 115 (03) :391-396
[3]  
BUCKLEY RH, 1986, J IMMUNOL, V136, P2398
[4]  
CAREY AH, 1992, AM J HUM GENET, V51, P964
[5]   SPECTRUM OF THE DIGEORGE SYNDROME [J].
CONLEY, ME ;
BECKWITH, JB ;
MANCER, JFK ;
TENCKHOFF, L .
JOURNAL OF PEDIATRICS, 1979, 94 (06) :883-890
[6]   A common region of 10p deleted in DiGeorge and velocardiofacial syndromes [J].
Daw, SCM ;
Taylor, C ;
Kraman, M ;
Call, K ;
Mao, JI ;
Schuffenhauer, S ;
Meitinger, T ;
Lipson, T ;
Goodship, J ;
Scambler, P .
NATURE GENETICS, 1996, 13 (04) :458-460
[7]   PREVALENCE OF 22Q11 MICRODELETIONS IN DIGEORGE AND VELOCARDIOFACIAL SYNDROMES - IMPLICATIONS FOR GENETIC-COUNSELING AND PRENATAL-DIAGNOSIS [J].
DRISCOLL, DA ;
SALVIN, J ;
SELLINGER, B ;
BUDARF, ML ;
MCDONALDMCGINN, DM ;
ZACKAI, EH ;
EMANUEL, BS .
JOURNAL OF MEDICAL GENETICS, 1993, 30 (10) :813-817
[8]   AGE-RELATED-CHANGES IN HUMAN BLOOD LYMPHOCYTE SUBPOPULATIONS [J].
ERKELLERYUKSEL, FM ;
DENEYS, V ;
YUKSEL, B ;
HANNET, I ;
HULSTAERT, F ;
HAMILTON, C ;
MACKINNON, H ;
STOKES, LT ;
MUNHYESHULI, V ;
VANLANGENDONCK, F ;
DEBRUYERE, M ;
BACH, BA ;
LYDYARD, PM .
JOURNAL OF PEDIATRICS, 1992, 120 (02) :216-222
[9]  
GATTI RA, 1972, J PEDIATR-US, V81, P920, DOI 10.1016/S0022-3476(72)80544-4
[10]  
HONG R, 1991, Immunodeficiency Reviews, V3, P1